Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/10/2020
SIETES contiene 93130 citas

 
 
 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A. Antipsychotics use: 2006–2013 trends in prevalence and incidence and characterization of users. Eur J Clin Pharmacol 2018;74:mayo. [Ref.ID 102512]
2. Cita con resumen
Maura G, Pariente A, Alla F, Billionnet C. Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a french nationwide cohort study. Pharmacoepidemiol Drug Saf 2017;26:1367-77. [Ref.ID 102133]
3. Cita con resumen
Billionnet C, Alla F, Bérigaud É, Pariente A, Maura G. Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases . Pharmacoepidemiol Drug Saf 2017;26:535-43. [Ref.ID 101959]
4. Cita con resumen
Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, Bégaud B, Pariente A. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study. Pharmacoepidemiol Drug Saf 2017;26:162-9. [Ref.ID 101951]
5.Tiene citas relacionadas Cita con resumen
Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G, on behalf of the Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 2016;354:i4857. [Ref.ID 100756]
6. Cita con resumen
Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, Bégaud B, Pariente A. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. BMJ 2016;353:i2231. [Ref.ID 100309]
7.Tiene citas relacionadas Cita con resumen
Billioti de Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Bégaud B. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ 2014;349:g5205. [Ref.ID 98229]
8. Cita con resumen
Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Pariente A, Blin P, Bénichou J, Bégaud B. Choice of denominator in case population studies: event rates for registration for liver transplantation after exposure to NSIADs in the SALT study in France. Pharmacoepidemiol Drug Saf 2013;22:160-7. [Ref.ID 94867]
9.Tiene citas relacionadas Cita con resumen
de Gage SB, Bégaud B, Pariente A. Benzodiazepines and dementia. Authors' reply. BMJ 2012;345:28-9. [Ref.ID 94180]
10.Tiene citas relacionadas Cita con resumen
Billioti de Gage SB, Bégaud B, Bazin F, Verdoux H, Dartigues J-F, Pérès K, Kurth T, Pariente A. Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:14. [Ref.ID 93062]
11.Tiene citas relacionadas Cita con resumen
Pariente A, Fourrier-Réglat A, Ducruet T, Farrington P, Béland S-G, Dartigues J-F, Moore N, Moride Y. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med 2012;172:648-53. [Ref.ID 92791]
12.Enlace a cita original Cita con resumen
Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenbbom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf 2011;20:1225-36. [Ref.ID 91664]
13. Cita con resumen
Pariente A, Daveluy A, Laribière-Bénard A, Miremont-Salamé G, Bégaud B, Moore N. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Drug Saf 2009;32:441-7. [Ref.ID 85937]
Seleccionar todas
 
 1 a 13 de 13